University Hospital Augsburg — Clinical Trial Site

21 Registered trials

9 Currently recruiting

Organisation

University Hospital Augsburg

Location

Augsburg, Germany

Identifier

ORG-100033069

Address

Stenglinstrasse 2, Kriegshaber, 86156, Germany

Departments

Childrens Hospital
Clinic for Anesthesiology and Surgical Intensive Care Medicine
Diagnostische und Interventionelle Radiologie und Neuroradiologie
Gynecology and Obstetrics
Hämatologie/Internistische Onkologie
I. Klinik für Kinder und Jugendliche, Hämatlogie/Onkologie
II
II. Medical Clinic
II. Medizinische Klinik
II. Medizinische Klinik, Hämatologie und Onkologie
III. Medical Clinic
Klinik für Kinder und Jugendliche
Klinik für Kinder- und Jugendmedizin
Nuclear Medicine
Schwäbisches Kinderkrebszentrum

Clinical trials at this site (21)

Search interface

ABTECT-2 – ABX464 Treatment Evaluation for ulcerative Colitis Therapy -2 Not authorised

2022-500536-11-00 Moderately to severely active ulcerative colitis 5
ABTECT-Maintenance – ABX464 Treatment Evaluation for ulcerative Colitis Therapy Not authorised

2022-500537-84-00 Moderately to severely active ulcerative colitis 5
Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Patie… Recruiting

2022-501876-24-00 Relapsed or Refractory (R/R) Chronic Lymphocytic Leukem 3 2022-06-17
A multi-center randomized, double blinded phase IIb trial evaluating oral pooled fecal microbiotherapy MaaT033 to prevent allogeneic hematop… Recruiting

2022-501831-18-00 Patients with hematologic malignancies and undergoing a 4 2023-09-13
The ACTION Study: ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy Recruiting

2022-502051-56-00 H3 K27M-mutant diffuse glioma 5 2023-04-28
A Randomized, Open-label, Phase 3 Study of Acalabrutinib in Combination with Rituximab and Reduced Dose CHOP (R-miniCHOP) in Older Adults wi… Recruiting

2022-501187-18-00 a. Diffuse large B-cell lymphoma (DLBCL) not otherwise 5 2023-04-24
CAPTOR-BC: COMPREHENSIVE ANALYSIS OF SPATIAL, TEMPORAL AND MOLECULAR PATTERNS OF RIBOCICLIB EFFICACY AND RESISTANCE IN ADVANCED BREAST CANCE… Recruiting

2022-500764-35-00 Patients with advanced HER2-negative, hormone receptor 6 2022-10-13
International Euro Ewing (iEuroEwing) trial for treatment optimisation in patients with Ewing sarcoma Recruiting

2022-501180-40-00 Ewing Sarcoma 5 2022-06-17
An international trial for children with atypical teratoid/rhabdoid tumours (ATRT) Recruiting

2022-501456-28-00 atypical teratoid/rhabdoid tumours (ATRT) 5 2020-07-20
International study for children and adolescents with standard risk ALK-positive anaplastic large cell lymphoma (ALCL) estimating the effica… Recruiting

2022-501454-11-00 standard risk ALK-positive anaplastic large cell lympho 5 2020-02-05
Phase III Clinical Trial for CPX-351 in Myeloid Leukemia in Children with Down Syndrome 2018 Ended

2022-501457-37-00 Myeloid Leukemia in Children with Down Syndrome 5 2024-10-28
A phase 3 multicentre, randomized, prospective, open-label trial of Ibrutinib monotherapy versus fixed-duration Venetoclax plus Obinutuzumab… Ended

2022-500439-35-00 treatment-naive chronic lymphocytic leukemia 5 2021-02-11
International multicenter, open-label clinical trial for the treatment of acute myeloid leukemia in children and adolescents Halted

2022-500783-35-00 Acute Myeloid Leukemia 5 2022-12-06
A Study to Evaluate CC-486 in Participants With Moderate or Severe Hepatic Impairment Compared With Normal Hepatic Function in Cancer Partic… Ended

2023-503427-26-00 Myeloid malignancies with moderate or severe hepatic im 3 2023-11-10
Efficacy and Tolerability of AP707 in Patients with chronic Pain due to Diabetic Polyneuropathy Ended

2022-500897-32-00 Chronic pain due to diabetic polyneuropathy 5 2023-11-02
Efficacy and Tolerability of AP707 in Patients with chronic Pain due to traumatic or post-operative peripheral Neuropathy Ended

2022-500898-13-00 Chronic Pain due to traumatic or post-operative periphe 5 2023-11-02
Efficacy and Tolerability of AP707 in Patients with chronic pain due to central Neuropathy of any Genesis Ended

2022-500899-66-00 Chronic pain due to central Neuropathy of any Genesis 5 2023-11-02
Efficacy and Tolerability of AP707 in Patients with Chronic Back Pain Ended

2022-502151-54-00 Chronic back pain 5 2023-11-02
A study to compare how well gadoquatrane works and its safety with an already available contrast agent for MRI in people with known or suspe… Ended

2022-501884-41-00 Contrast enhancement in magnetic resonance imaging for 5 2023-09-29
Efficacy of [18F]florbetaben PET for diagnosis of cardiac AL amyloidosis Ended

2022-500186-27-00 ATTR Amyloidosis 5 2023-01-11
Magrolimab plus intensive chemotherapy in newly diagnosed “ELN intermediate or poor-risk” AML patients intended to undergo allogeneic stem … Ended

2022-502040-13-00 High-risk Myelodysplastic neoplasia 4